Johnson & Johnson announced positive topline results from ICONIC-LEADa, a pivotal Phase 3 investigational study of icotrokinra, or JNJ-2113, the first targeted oral peptide that selectively blocks the ...
Biolojic Design, a biotechnology company that uses computational biology and artificial intelligence (AI) to transform antibodies into programmable, intelligent medicines, today announced that it is ...
GlobalData on MSN4d
Johnson & Johnson MedTech announces partnership for soft tissue solutions"Johnson & Johnson MedTech announces partnership for soft tissue solutions" was originally created and published by Medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback